| Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity G Musso, R Gambino, M Cassader, G Pagano Annals of medicine 43 (8), 617-649, 2011 | 1586 | 2011 |
| Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association G Pagano, G Pacini, G Musso, R Gambino, F Mecca, N Depetris, ... Hepatology 35 (2), 367-372, 2002 | 961 | 2002 |
| Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis G Musso, R Gambino, F De Michieli, M Cassader, M Rizzetto, M Durazzo, ... Hepatology 37 (4), 909-916, 2003 | 927 | 2003 |
| Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms E Bugianesi, A Gastaldelli, E Vanni, R Gambino, M Cassader, S Baldi, ... Diabetologia 48, 634-642, 2005 | 883 | 2005 |
| Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? G Musso, R Gambino, M Cassader Diabetes care 33 (10), 2277-2284, 2010 | 805 | 2010 |
| Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of … G Musso, M Cassader, F Rosina, R Gambino Diabetologia 55, 885-904, 2012 | 754 | 2012 |
| Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD) G Musso, R Gambino, M Cassader Progress in lipid research 48 (1), 1-26, 2009 | 753 | 2009 |
| A meta‐analysis of randomized trials for the treatment of nonalcoholic fatty liver disease G Musso, R Gambino, M Cassader, G Pagano Hepatology 52 (1), 79-104, 2010 | 742 | 2010 |
| Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes G Musso, R Gambino, M Cassader Annual review of medicine 62, 361-380, 2011 | 703 | 2011 |
| Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis G Musso, R Gambino, JH Tabibian, M Ekstedt, S Kechagias, ... PLoS medicine 11 (7), e1001680, 2014 | 626 | 2014 |
| Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity E Bugianesi, U Pagotto, R Manini, E Vanni, A Gastaldelli, R de Iasio, ... The journal of clinical endocrinology & metabolism 90 (6), 3498-3504, 2005 | 524 | 2005 |
| Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis G Musso, R Gambino, M Cassader Progress in lipid research 52 (1), 175-191, 2013 | 407 | 2013 |
| Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies G Musso, M Cassader, R Gambino Nature reviews Drug discovery 15 (4), 249-274, 2016 | 379 | 2016 |
| Non‐alcoholic fatty liver disease from pathogenesis to management: an update G Musso, R Gambino, M Cassader Obesity Reviews 11 (6), 430-445, 2010 | 368 | 2010 |
| Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease G Musso, R Gambino, M Durazzo, G Biroli, M Carello, E Faga, G Pacini, ... Hepatology 42 (5), 1175-1183, 2005 | 341 | 2005 |
| A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials G Musso, R Gambino, M Cassader, G Pagano Annals of medicine, 2012 | 328 | 2012 |
| Thiazolidinediones and advanced liver fibrosis in nonalcoholic steatohepatitis: a meta-analysis G Musso, M Cassader, E Paschetta, R Gambino JAMA internal medicine 177 (5), 633-640, 2017 | 321 | 2017 |
| An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. G Pagano, P Cavallo-Perin, M Cassader, A Bruno, A Ozzello, P Masciola, ... The Journal of clinical investigation 72 (5), 1814-1820, 1983 | 309 | 1983 |
| Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial S Bo, G Ciccone, C Baldi, L Benini, F Dusio, G Forastiere, C Lucia, C Nuti, ... Journal of general internal medicine 22, 1695-1703, 2007 | 283 | 2007 |
| Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese … G Musso, R Gambino, S Bo, B Uberti, G Biroli, G Pagano, M Cassader Diabetes care 31 (3), 562-568, 2008 | 269 | 2008 |
